NCT01645930View on ClinicalTrials.gov

Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

December 17, 2012

Primary Completion Date

July 14, 2014

Study Completion Date

April 11, 2017

Conditions
Multiple Myeloma
Interventions
DRUG

Ixazomib

Ixazomib capsules

DRUG

Lenalidomide

Lenalidomide capsules

DRUG

Dexamethasone

Dexamethasone tablets

Trial Locations (5)

Unknown

Pokfulam

Shatin

Singapore

Incheon

Seoul

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY